ENT Biotech Solutions scores $100K from Michigan Pre-Seed Fund
ENT Biotech Solutions recently secured $100,000 in seed capital from the Michigan Pre-Seed Fund 2.0, which is part of a $1 million angel round for the TechTown-based startup.
“We are in the process of closing it,” says Andrea Roumell Dickson, CEO of ENT Biotech Solutions.
The two-year-old startup is developing the Elasso, a single-use, disposable device designed as a cost-effective too for reducing the tedious nature of adenoid and tonsil surgery. The one-step tool cuts, cauterizes, and removes tissue, combining the advantages of heating and cutting technologies.
ENT Biotech Solutions is currently waiting for a clearance from the FDA to move ahead with commercialization. That clearance could come as soon as this fall.
“As soon as we receive that we have a green light to manufacture. Our tooling is already cut,” Roumell Dickson says. “We are able to very rapidly ramp up for production.”
Source: Andrea Roumell Dickson, CEO of ENT Biotech Solutions
Writer: Jon Zemke
Read more about Metro Detroit’s growing entrepreneurial ecosystem at SEMichiganStartup.com.
Related Articles
Women and wealth: Tips for navigating your lifelong financial journey
Are you saving up for a house, or retiring early? Where do you want to be in the next ten or twenty years? Everyone’s financial situation is unique, so it’s important to think about these questions.
Partner Partner Content How Detroit’s New Chase Community Manager Can Help Empower Your Financial Journey
Anthony Miller joins Gail Taylor and Annette Washington as Detroit’s newest Chase Community Manager. This dynamic trio— part of a national network of Community Managers in all lower 48 states—helps to build stronger financial futures in Detroit.
Partner Partner Content Rising optimism among small and middle market business leaders suggests growth for Michigan
Both small and midsize business leaders are feeling more confident to pursue growth opportunities, embrace emerging technologies and, in some cases, forge new strategic partnerships.
